Building on Pasteur's legacy: producing vaccines in Africa.
dc.contributor.affiliation | Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia. | |
dc.contributor.affiliation | Centre for the AIDS Programme of Research in South Africa (CAPRISA), Nelson R Mandela Medical School, University of KwaZulu-Natal, Durban 4001, South Africa; Columbia University, New York, NY, USA. Electronic address: salim.abdoolkarim@caprisa.org. | |
dc.contributor.author | Karim SSA | |
dc.contributor.author | Sikazwe I | |
dc.date.accessioned | 2025-07-10T11:06:42Z | |
dc.date.issued | 2022-Dec-17 | |
dc.identifier.doi | 10.1016/S0140-6736(22)01901-8 | |
dc.identifier.uri | https://pubs.cidrz.org/handle/123456789/10919 | |
dc.identifier.uri.pubmed | https://pubmed.ncbi.nlm.nih.gov/36528368/ | |
dc.source | Lancet (London, England) | |
dc.title | Building on Pasteur's legacy: producing vaccines in Africa. |